Current Surgical has secured $3.2 million in seed funding for its innovative cancer treatment technology

Sublime, an email tech startup based in Washington DC, has secured $9.8 million in funding.

             

Image Source: techcrunch.com

Tech-guided needle uses micro-sized sensors to locate tumors

             

Destroy tumors using thermal ablation process

             

Aims to minimize damage to surrounding tissue

             

Funds will be used to reduce size of the technology and hire new team members

             

Image Source: vator.tv/news

Long-term goal is to apply technology to all solid tumors and other conditions

             

Image Source: www.roboticsbusinessreview.com

Potential to revolutionize cancer treatment

             

Makes tumor removal easier for patients

             

Congrats to Current Surgical on this exciting milestone!

             

Stay tuned for more updates on this game-changing technology!